G
Glenn J. Gormley
Researcher at Merck & Co.
Publications - 47
Citations - 3995
Glenn J. Gormley is an academic researcher from Merck & Co.. The author has contributed to research in topics: Finasteride & Prostate. The author has an hindex of 26, co-authored 47 publications receiving 3855 citations. Previous affiliations of Glenn J. Gormley include St Bartholomew's Hospital & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Glenn J. Gormley,Elizabeth Stoner,Reginald C. Bruskewitz,Julianne Imperato-McGinley,Patrick C. Walsh,John D. McConnell,Gerald L. Andriole,Jack Geller,Bruce Bracken,J S Tenover +9 more
TL;DR: The effect of finasteride (1 mg and 5 mg) on prostate hyperplasia was evaluated in 895 men with prostate cancer in a double-blind study as discussed by the authors.
Journal ArticleDOI
Finasteride in the treatment of men with androgenetic alopecia
Keith D. Kaufman,Elise A. Olsen,David A. Whiting,Ronald C. Savin,Richard L. DeVillez,Wilma F. Bergfeld,Vera H. Price,Dominique Van Neste,Janet L. Roberts,Maria K. Hordinsky,Jerry Shapiro,Bruce Binkowitz,Glenn J. Gormley +12 more
TL;DR: In men with male pattern hair loss, finasteride 1 mg/d slowed the progression of hair loss and increased hair growth in clinical trials over 2 years.
Journal ArticleDOI
Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial
Evan A. Stein,D. Roger Illingworth,Peter O. Kwiterovich,Chris A. Liacouras,Martti A. Siimes,Marc S. Jacobson,Thomas G. Brewster,Paul N. Hopkins,Michael H. Davidson,Kevin Graham,Frederick Arensman,Robert H. Knopp,Carlos A. Dujovne,Christine L. Williams,Jonathan L. Isaacsohn,Carol A. Jacobsen,Peter M. Laskarzewski,Sharon Ames,Glenn J. Gormley +18 more
TL;DR: This study in adolescent boys with HeFH confirmed the LDL-C-reducing effectiveness of lovastatin, and comprehensive clinical and biochemical data on growth, hormonal, and nutritional status indicated no significant differences between Lovastatin and placebo over 48 weeks, although further study is required.
Journal ArticleDOI
Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
Jonathan M. Edelman,Jennifer A. Turpin,Edwin A. Bronsky,Jay Grossman,James P. Kemp,Asma F. Ghannam,Paul DeLucca,Glenn J. Gormley,David S. Pearlman +8 more
TL;DR: The hypothesis that the bronchoprotective effects of montelukast were greater than those of salmeterol in patients with chronic asthma who experienced exercise-induced bronchoconstriction was tested.
Journal ArticleDOI
Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*
Glenn J. Gormley,Elizabeth Stoner,Roger S. Rittmaster,Hall Gregg,David L. Thompson,Kenneth C. Lasseter,Peter H. Vlasses,Evan A. Stein +7 more
TL;DR: Finasteride is well tolerated by normal volunteers and results in significant suppression of serum DHT at all doses tested, and the T/DHT ratio increased with all doses and returned to baseline when drug was discontinued.